Lux Health Tech Acquisition Corp.’s $300 Million Initial Public Offering

Latham & Watkins LLP represented Lux Health Tech Acquisition Corp. in the offering.

Lux Health Tech Acquisition Corp. (the Company) has announced the pricing of its initial public offering of 30,000,000 units at a price of US$10.00 per unit. The units will be listed on the Nasdaq Stock Market, LLC (Nasdaq) and will trade under the ticker symbol “LUXAU”. Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-third of one warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at an exercise price of US$11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “LUXA” and “LUXAW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Credit Suisse Securities (USA) LLC acted as sole book-running manager for the offering and Stifel, Nicolaus & Company, Incorporated acted as lead manager. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.

Lux Health Tech Acquisition Corp. is a blank check company sponsored by an affiliate of Lux Capital and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses at the intersection of the healthcare and technology industries.

Latham & Watkins LLP represented Lux Health Tech Acquisition Corp. in the offering with a corporate deal team led by Houston partner Ryan Maierson (Picture), with Houston associates Ryan Lynch, Madeleine Neet, Paul Robe, and Trevor Bossi and Washington, D.C. associate Ashlyn Royall. Advice was also provided on tax matters by Houston partners Tim Fenn and Bryant Lee, with Houston associate Chelsea Munoz-Patchen; and on investment funds matters by Houston partner Ivana Rouse, with Houston associate Cassy Romano.

Involved fees earner: Trevor Bossi – Latham & Watkins; Timothy Fenn – Latham & Watkins; Ivana Rouse – Latham & Watkins; Bryant Lee – Latham & Watkins; Ryan Lynch – Latham & Watkins; Ryan Maierson – Latham & Watkins; Chelsea Marie Muñoz-Patchen – Latham & Watkins; Madeleine Neet – Latham & Watkins; Paul Robe – Latham & Watkins; Ashlyn Royall – Latham & Watkins;

Law Firms: Latham & Watkins;

Clients: Lux Health Tech Acquisition Corp.;

Author: Ambrogio Visconti